Y0001289

Magnolol

European Pharmacopoeia (EP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 528-43-8

Synonym(S): 2,2′-Bichavicol, 5,5′-Diallyl-2,2′-biphenyldiol

Select a Size

Pack Size SKU Availability Price
20 MG Y0001289-20-MG In Stock ₹ 20,567.50

Y0001289 - 20 MG

₹ 20,567.50

In Stock

Quantity

1

Base Price: ₹ 20,567.50

GST (18%): ₹ 3,702.15

Total Price: ₹ 24,269.65

grade

pharmaceutical primary standard

API family

magnolol, magnolia officialis

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

SMILES string

Oc1ccc(CC=C)cc1-c2cc(CC=C)ccc2O

InChI

1S/C18H18O2/c1-3-5-13-7-9-17(19)15(11-13)16-12-14(6-4-2)8-10-18(16)20/h3-4,7-12,19-20H,1-2,5-6H2

InChI key

VVOAZFWZEDHOOU-UHFFFAOYSA-N

Related Products

Img

Sigma Aldrich

Y0001290

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

Y0000040

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

Y0001093

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

Y0001167

European Pharmacopoeia (EP) Referen...

Img

Sigma Aldrich

Y0001205

European Pharmacopoeia (EP) Referen...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Magnolol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
  • Biochem/physiol Actions: Magnolol is a bioactive plant component isolated from the root and stem bark of Magnolia officinalis with antifungal, antibacterial and antioxidant effects. Magnolol also demonstrates anti-inflammatory activity by interferring with NF-κB signaling. It also appears to have anti-inflammatory properties related to vascular disorders such as atherosclerosis due to its ability to inhibit IL-6-induced STAT3 activation.
  • Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS05,GHS07,GHS09

Signal Word

Danger

Hazard Statements

H315,H318,H335,H411

Precautionary Statements

P273 - P280 - P302 + P352 - P305 + P351 + P338 + P310

Hazard Classifications

Aquatic Chronic 2 - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable